非アルコール性脂肪肝炎（NASH）は、肝臓の炎症と線維化を特徴とする重度の非アルコール性脂肪性肝疾患であり、肥満やメタボリックシンドロームとの関連が指摘されています。世界全体では、NASHの有病率は2018年の2億6,400万人から2023年には2億9,600万人に増加し、2030年には3億4,200万人に達すると予測されています。NASH治療薬市場は、進行を抑制し、脂肪蓄積を減らし、肝硬変を予防する治療法に重点を置いており、Madrigal Pharmaceuticals社が2024年3月にFDAの承認を取得したレスメチロムは、中等度から進行期のNASH線維化に対する初の治療薬となります。この業界は、深刻なアンメットニーズを抱える蔓延への対応と、代謝を標的とした治療へのシフトを背景に、積極的な研究開発が進められていることが特徴です。
世界の非アルコール性脂肪肝炎治療薬市場は、2025年には3億米ドルから6億米ドルに達すると推定されており、2030年までには100%から110%という驚異的な年平均成長率（CAGR）で成長し、100億米ドルから240億米ドルに達する可能性があります。この爆発的な成長は、レスメチロムの承認と堅調なパイプラインの活動を反映しています。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Non-Alcoholic Steatohepatitis Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in North America (2020-2030)
8.1 Non-Alcoholic Steatohepatitis Drug Market Size
8.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in South America (2020-2030)
9.1 Non-Alcoholic Steatohepatitis Drug Market Size
9.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in Asia & Pacific (2020-2030)
10.1 Non-Alcoholic Steatohepatitis Drug Market Size
10.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in Europe (2020-2030)
11.1 Non-Alcoholic Steatohepatitis Drug Market Size
11.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in MEA (2020-2030)
12.1 Non-Alcoholic Steatohepatitis Drug Market Size
12.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Non-Alcoholic Steatohepatitis Drug Market (2020-2025)
13.1 Non-Alcoholic Steatohepatitis Drug Market Size
13.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
Chapter 14 Global Non-Alcoholic Steatohepatitis Drug Market Forecast (2025-2030)
14.1 Non-Alcoholic Steatohepatitis Drug Market Size Forecast
14.2 Non-Alcoholic Steatohepatitis Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Non-Alcoholic Steatohepatitis Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 AstraZeneca PLC
15.1.1 Company Profile
15.1.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.1.3 SWOT Analysis of AstraZeneca PLC
15.1.4 AstraZeneca PLC Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.2 Eli Lilly
15.2.1 Company Profile
15.2.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.2.3 SWOT Analysis of Eli Lilly
15.2.4 Eli Lilly Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.3 Gilead Sciences
15.3.1 Company Profile
15.3.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.3.3 SWOT Analysis of Gilead Sciences
15.3.4 Gilead Sciences Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.4 Merck & Co. Inc.
15.4.1 Company Profile
15.4.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.4.3 SWOT Analysis of Merck & Co. Inc.
15.4.4 Merck & Co. Inc. Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.5 Novo Nordisk
15.5.1 Company Profile
15.5.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.5.3 SWOT Analysis of Novo Nordisk
15.5.4 Novo Nordisk Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.6 Novartis AG
15.6.1 Company Profile
15.6.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.6.3 SWOT Analysis of Novartis AG
15.6.4 Novartis AG Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.7 Pfizer Inc.
15.7.1 Company Profile
15.7.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.7.3 SWOT Analysis of Pfizer Inc.
15.7.4 Pfizer Inc. Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.8 Roche Holding AG
15.8.1 Company Profile
15.8.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.8.3 SWOT Analysis of Roche Holding AG
15.8.4 Roche Holding AG Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.9 Enanta Pharmaceuticals Inc.
15.9.1 Company Profile
15.9.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.9.3 SWOT Analysis of Enanta Pharmaceuticals Inc.
15.9.4 Enanta Pharmaceuticals Inc. Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.10 Ionis Pharmceuticals Inc.
15.10.1 Company Profile
15.10.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.10.3 SWOT Analysis of Ionis Pharmceuticals Inc.
15.10.4 Ionis Pharmceuticals Inc. Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Non-Alcoholic Steatohepatitis Drug Report
Table Data Sources of Non-Alcoholic Steatohepatitis Drug Report
Table Major Assumptions of Non-Alcoholic Steatohepatitis Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Non-Alcoholic Steatohepatitis Drug Picture
Table Non-Alcoholic Steatohepatitis Drug Classification
Table Non-Alcoholic Steatohepatitis Drug Applications
Table Drivers of Non-Alcoholic Steatohepatitis Drug Market
Table Restraints of Non-Alcoholic Steatohepatitis Drug Market
Table Opportunities of Non-Alcoholic Steatohepatitis Drug Market
Table Threats of Non-Alcoholic Steatohepatitis Drug Market
Table Covid-19 Impact For Non-Alcoholic Steatohepatitis Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Non-Alcoholic Steatohepatitis Drug
Table Cost Structure Analysis of Non-Alcoholic Steatohepatitis Drug
Table Key End Users
Table Latest News of Non-Alcoholic Steatohepatitis Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Non-Alcoholic Steatohepatitis Drug Market
Table Policy of Non-Alcoholic Steatohepatitis Drug Market
Table 2020-2030 North America Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2020-2030 North America Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2020-2030 North America Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2020-2025 North America Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2020-2025 North America Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2020-2030 North America Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2020-2030 United States Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Canada Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Mexico Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 South America Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2020-2030 South America Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2020-2030 South America Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2020-2025 South America Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2020-2025 South America Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2020-2030 South America Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2020-2030 Brazil Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Argentina Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Chile Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Peru Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2020-2030 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2020-2030 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2020-2025 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2020-2025 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2020-2030 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2020-2030 China Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 India Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Japan Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 South Korea Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Southeast Asia Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Australia Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Europe Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2020-2030 Europe Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2020-2030 Europe Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2020-2025 Europe Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2020-2025 Europe Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2020-2030 Europe Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2020-2030 Germany Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 France Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 United Kingdom Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Italy Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Spain Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Belgium Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Netherlands Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Austria Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Poland Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Russia Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 MEA Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2020-2030 MEA Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2020-2030 MEA Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2020-2025 MEA Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2020-2025 MEA Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2020-2030 MEA Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2020-2030 Egypt Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Israel Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 South Africa Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2030 Turkey Non-Alcoholic Steatohepatitis Drug Market Size
Table 2020-2025 Global Non-Alcoholic Steatohepatitis Drug Market Size by Region
Table 2020-2025 Global Non-Alcoholic Steatohepatitis Drug Market Size Share by Region
Table 2020-2025 Global Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2020-2025 Global Non-Alcoholic Steatohepatitis Drug Market Share by Application
Table 2020-2025 Global Non-Alcoholic Steatohepatitis Drug Key Vendors Revenue
Figure 2020-2025 Global Non-Alcoholic Steatohepatitis Drug Market Size and Growth Rate
Table 2020-2025 Global Non-Alcoholic Steatohepatitis Drug Key Vendors Market Share
Table 2020-2025 Global Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2020-2025 Global Non-Alcoholic Steatohepatitis Drug Market Share by Type
Table 2025-2030 Global Non-Alcoholic Steatohepatitis Drug Market Size by Region
Table 2025-2030 Global Non-Alcoholic Steatohepatitis Drug Market Size Share by Region
Table 2025-2030 Global Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2025-2030 Global Non-Alcoholic Steatohepatitis Drug Market Share by Application
Table 2025-2030 Global Non-Alcoholic Steatohepatitis Drug Key Vendors Revenue
Figure 2025-2030 Global Non-Alcoholic Steatohepatitis Drug Market Size and Growth Rate
Table 2025-2030 Global Non-Alcoholic Steatohepatitis Drug Key Vendors Market Share
Table 2025-2030 Global Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2025-2030 Non-Alcoholic Steatohepatitis Drug Global Market Share by Type
